Company / EPS (Diluted)
TENAX THERAPEUTICS, INC. EPS (Diluted) History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.15
FY2025
5-year range
-$31.04 / -$1.15
FY2021-FY2025
Trend
+96.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.71 to $-1.15 over the past 9 years.
Based on SEC 10-K filings.
-1.15 in FY2025.
Improved from $-2.71 to $-1.15 over the past 9 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 96.3% year-over-year.
- Peak eps (diluted) was recorded in FY2012.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.15 | +96.3% |
| FY2024 | -$31.04 | -1045.4% |
| FY2016 | -$2.71 | +0.0% |
| FY2015 | -$2.71 | +59.4% |
| FY2014 | -$6.68 | +52.5% |
| FY2013 | -$14.07 | -3026.7% |
| FY2012 | -$0.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026